Non-Clinical Efficacy and Safety Studies on G1XCGD, a lentiviral vector for ex vivo gene therapy of Chronic Granulomatous Disease
semanticscholar(2018)
摘要
1Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany 2Division of Hematology/Oncology, Boston Children’s Hospital, Boston, Massachusetts, USA. 3Harvard Medical School, Boston, Massachusetts, USA 4Hannover Medical School, Institute of Experimental Hematology, Hannover, Germany 5Centre for Immunodeficiency, UCL Institute of Child Health, and Great Ormond Street Hospital for Children NHS Trust London, UK 6Genethon, Evry, France 7LOEWE-Research Group, Paul-Ehrlich-Institute, Langen, Germany 8Hannover Medical School, Cluster of Excellence REBIRTH, Hannover, Germany
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要